Marinus Pharmaceuticals reported $248.1M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.28B 1.63B
Amgen AMGN:US $ 129.97B 0.89B
Aptinyx Inc APTX:US $ 0.04B 0.12B
Biogen BIIB:US $ 29.87B 1.08B
Eisai 4523:JP 1697.85B 16.31B
Enanta Pharmaceuticals ENTA:US $ 0.98B 0.48B
Esperion Therapeutics ESPR:US $ 0.4B 0.11B
Gilead Sciences GILD:US $ 77.53B 2.87B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
Intra Cellular Therapies ITCI:US $ 5.38B 0.37B
Marinus Pharmaceuticals MRNS:US $ 0.18B 0.17B
Minerva Neurosciences NERV:US $ 0.02B 0.02B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Ptc Therapeutics PTCT:US $ 2.86B 0.2B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Supernus Pharmaceuticals SUPN:US $ 1.54B 0.18B
UCB UCB:BB 15.68B 3.83B
Vertex Pharmaceuticals VRTX:US $ 72.14B 5.45B
YTE INCY:US $ 16.83B 0.75B